Stanford Molecular and Cellular Characterization Laboratory (Prostate)

Dr. Brooks and team will focus on prostate evolution and heterogeneity. They will investigate the early genomic evolution of good and adverse outcome prostate cancer through examination of genomic and gene-expression changes early in the development and in the evolution of prostate cancer. From this they will also evaluate candidate prognostic genomic features. Additionally, the team will define the genomic heterogeneity of good and adverse outcome prostate cancer through examination of genomic and gene expression changes, and protein expression and glycoproteomic alterations in localized prostate cancer. Leveraging this work they will investigate correlations of integrated genomic, transcript, protein and glycoprotein changes in localized prostate cancers with clinical outcomes.
2020-02-19
Yes